Localization of medullary thyroid carcinoma metastasis in a multiple endocrine neoplasia type 2A patient by 6-[18F]-fluorodopamine positron emission tomography

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 2, 2003, Pages 637-641

  Gourgiotis, Loukas ^a   Sarlis, Nicholas J ^a   Reynolds, James C ^b   Vanwaes, Carter ^c   Merino, Maria J ^d   Pacak, Karel ^c,e  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 FLUORODOPA F 18; CATECHOLAMINE; METADRENALIN;

ADULT; ANAMNESIS; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CASE REPORT; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE URINE LEVEL; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; ENDOCRINE TUMOR; FEMALE; HUMAN; HUMAN TISSUE; METASTASIS; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THYROID CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME;

ADULT; CARCINOMA, MEDULLARY; DOPAMINE; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; THYROID NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

POMACANTHUS MACULOSUS;

EID: 0037329190     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021354     Document Type: Article

References (23)

1. Goldstein DS, Chang PC, Eisenhofer G, Miletich R, Finn R, Bacher J, Kirk KL, Bacharach S, Kopin IJ 1990 Positron emission tomographic imaging of cardiac sympathetic innervation and function. Circulation 81:1606-1621
2. Pacak K, Eisenhofer G, Carrasquillo JA, Chen CC, Li ST, Goldstein DS 2001 6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension 38:6-8
3. Pacak K, Goldstein DS, Doppman JL, Shulkin BL, Udelsman R, Eisenhofer G 2001 A "pheo" lurks: novel approaches for locating occult pheochromocytoma. J Clin Endocrinol Metab 86:3641-3646
4. Moley JF 1995 Medullary thyroid cancer. Surg Clin North Am 75:405-420
5. Chi DD, Moley JF 1998 Medullary thyroid carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia. Surg Oncol Clin North Am 7:681-706
6. Ball DW, Baylin SB, de Bustros AC 1996 Medullary thyroid carcinoma. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid, ed 7. Philadelphia: Lippincott Raven; 946-960
7. Lewington VJ, Clarke SE 2001 Isotopic evaluation and therapy in patients with malignant endocrine disease. Best Pract Res Clin Endocrinol Metab 15:225-239
8. Bombardieri E, Maccauro M, De Deckere E, Savelli G, Chiti A 2001 Nuclear medicine imaging of neuroendocrine tumours. Ann Oncol 12:S51-S61
9. Sisson JC, Shulkin BL 1999 Nuclear medicine imaging of pheochromocytoma and neuroblastoma. Q J Nucl Med 43:217-223
10. Rubello D, Bui C, Casara D, Gross MD, Fig LM, Shapiro B 2002 Functional scintigraphy of the adrenal gland. Eur J Endocrinol 147:13-28
11. Behr TM, Gotthardt M, Barth A, Behe M 2001 Imaging tumors with peptide-based radioligands. Q J Nucl Med 45:189-200
12. Arslan N, Ilgan S, Yuksel D, Serdengecti M, Bulakbasi N, Ugur O, Ozguven MA 2001 Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery. Clin Nucl Med 26:683-688
13. Berna L, Cabezas R, Mora J, Torres G, Estorch M, Carrio I 1995 111Inoctreotide and 99mTc(V)-dimercaptosuccinic acid studies in the imaging of recurrent medullary thyroid carcinoma. J Endocrinol 144:339-345
14. Krausz Y, Rosler A, Guttmann H, Ish-Shalom S, Shibley N, Chisin R, Glaser B 1999 Somatostatin receptor scintigraphy for early detection of regional and distant metastases of medullary carcinoma of the thyroid. Clin Nucl Med 24:256-260
15. Limouris GS, Giannakopoulos V, Stavraka A, Toubanakis N, Vlahos L 1997 Comparison of In-111 pentetreotide, Tc-99m (V)-DMSA and I-123 MIBG scintimaging in neural crest tumors. Anticancer Res 17:1589-1592
16. Ugur O, Kostakglu L, Güler N, Caner B, Uysal U, Elahi N, Halilioglu M, Yuksel D, Aras T, Bayhan H, Bekdik C 1996 Comparison of 99mTc(V)-DMSA, 201T1 and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid. Eur J Nucl Med 23:1367-1371
17. Diehl M, Risse JH, Brandt-Mainz K, Dietlein M, Bohuslavizki KH, Matheja P, Lange H, Bredow J, Korber C, Grunwald F 2001 Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study. Eur J Nucl Med 28:1671-1676
18. Thomas CC, Cowan RJ, Albertson DA, Cooper MR 1994 Detection of medullary carcinoma of the thyroid with I-131 MIBG. Clin Nucl Med 19:1066-1068
19. Reiners C, Eilles C, Spiegel W, Becker W, Borner W 1986 Immunoscintigraphy in medullary thyroid cancer using an 123I- or 111In-labelled monoclonal anti-CEA antibody fragment. Nuklearmedizin 25:227-231
20. Manil L, Boudet F, Motte P, Gardet P, Saccavini JC, Lumbroso JD, Schlumberger M, Caillou B, Bazin JP, Ricard M, Bellet D, Bohuon C, Tubiana M, Di Paola R, Parmentier C 1989 Positive anticalcitonin immunoscintigraphy in patients with medullary thyroid carcinoma. Cancer Res 49:5480-5485
21. Glowniak JV, Kilty JE, Amara SG, Hoffman BJ, Turner FE 1993 Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters. J Nucl Med 34:1140-1146
22. Chatal JF, Le Bodic MF, Kraeber-Bodere F, Rousseau C, Resche I 2000 Nuclear medicine applications for neuroendocrine tumors. World J Surg 24:1285-1289
23. Oishi S, Sasaki M, Sato T, Hirota Y, Takahashi M 1986 Imaging and uptake mechanism of 131I-meta-iodobenzylguanidine in medullary thyroid carcinoma. Endocrinol Jpn 33:309-315